Tag: SASSI-A3

Skillfully Using the SASSI

We want clinicians to find the SASSI to be helpful in their work in a way that enables them to affect the lives of their clients in a positive manner.

When a client is unable to acknowledge (sincerely deluded) or unwilling to accept they may have a problem, a clinician’s skillful and caring feedback on SASSI results may help break through those barriers and enable the client to take the courageous step toward recovery.

If you would like to learn more about clinically interpreting SASSI profiles, we encourage you to join us for one of Clinical Interpretation trainings. For more information on live, on-demand, and in-person workshops, please visit https://sassi.com/sassi-training/

Free assistance interpreting SASSI results is available M-F 1-5 pm ET at 800.726-0526 Option 2.

An Adolescent Trying to Mix Things Up!

The message this Adolescent was trying to send is as confused as he must be. A lot of contradictions in the numbers needed to be sorted out and made sense of.

This 16-year-old male responded to the FVA and FVOD questions for his whole lifetime.

The Prescription Drug Scale result was zero.

The VAL check was 4.

He met the criteria for a High Probability of a Substance Use Disorder based on Rules 1, 5, 6 and 7. A reminder, it requires only 1 yes to the 8 rules to meet the criteria for High Probability. More “yes’s” does not mean a more severe problem. Severity of a Substance Use Disorder is determined with a diagnosis from the DSM-5.

Another reminder, content analysis of the Face Valid scales i.e. FVA, FVOD, FRISK, ATT, SYM and Rx individual items can be examined to generate information regarding under what circumstances substances are used and with whom, along with underlying emotional reasons.

The FVA of 7 is elevated enough to meet the criteria of Rule 1.  The FVOD of 2 is below average and within the norm.

The FRISK score of 0 proves to be interesting given the context of the psychosocial history of this individual. It may be he did not want to disclose information regarding his friends or family.

The ATT score of 6 is highly elevated above the 98th percentile. This indicates he has a strong value and belief system regarding the use of substances. He may believe that everyone uses and that may be the case in his world.

The SYM score of 3 is within the norm so from his perspective, he has experienced minimal symptoms or consequences of his usage.

The OAT score of 7 is elevated above the 85th percentile so clinically significant but coupled with an higher SAT score of 6 as graphed is somewhat muted. On the one hand, an elevated OAT score indicates he can acknowledge personal limitations and shortcomings and may identify with other substance users though he may not want to change. On the other hand, the elevated SAT score can indicate denial or lack of awareness and insight or detachment from feelings.

The DEF score of 6 is within the norm and below average which can indicate self-esteem issues. It is a bit surprising the DEF score, in this case, is not elevated. The client was not defensive completing this questionnaire.

The SAM score, by itself, has no clinical interpretation.

The COR score of 5 is within the norm so there is no clinical interpretation.

What the psychosocial interview revealed: The client had a history of vaping nicotine with friends and had completed a Substance Use Education course. However, the client was smoking pot at home and minimizing his use. He was described as lying and manipulative. It was also disclosed his father is in recovery. As we all know, attitudes around Marijuana not being addictive or even a “drug” have been rapidly changing along with the legalization of Marijuana. However, the client’s risk of developing a significant risk of a substance use disorder is escalated by a family history of addiction.

Addressing the VAL score of 4:  With the High Probability of a Substance Use Disorder result, the VAL check score does NOT come into play. It would only be impactful if he had come up with a LOW Probability of a SUD. However, this score is quite high, and the administrator would rightly suspect the client was trying to skew the results even if it had no impact on the result.

Clinical Q&A – Please Join Us | Register Now!

We welcome you to join us for a free one-hour online SASSI Q&A session hosted by our Clinical Director, David Helton, LMSW, LCDC. Whether you’re new to the SASSI, considering using the SASSI, or a seasoned veteran at screening with the SASSI, everyone is welcome. The Q&A is scheduled from Noon-1pm ET on: November 12th. You can save your spot by clicking here. We welcome you to share profiles to discuss with the group by sending them (de-identified) via email any time prior to the session to scarlett@sassi.com. These profiles will help others learn about the SASSI and offer insight into the various profile configurations.

Note: Q&A sessions do not provide CEUs and are not a substitute for SASSI Training.

Navigating Change: A Minimal Price Increase at The SASSI Institute

In the dynamic landscape of addiction screening, assessment and intervention, The SASSI Institute remains dedicated to providing high-quality, reliable tools to professionals across the globe. As we continue to enhance our services and maintain the highest standards, we must occasionally adjust our pricing. Today, we want to discuss a 2025 minimal price increase for our products and services and how it will impact our valued clients.

Why the Increase?

The decision to implement a price increase is never taken lightly. Our commitment to delivering top-notch screening tools is unwavering, and maintaining this level of excellence requires ongoing investment. Here are the primary reasons behind this change:

  1. Continuing Research and Development:
    • Continuous improvement of our screening tools and delivery options to ensure they remain at the cutting edge of addiction science.
    • Investment in new technologies and methodologies to enhance the accuracy and reliability of our screening tools and services.
  2. Operational Costs:
    • Increases in costs for materials, production, and distribution.
    • Investments in better infrastructure to support seamless customer experiences.

We understand that any change in pricing can raise concerns, especially in fields where budgets are often tight. Therefore, we have made every effort to keep this increase minimal and manageable. Please note that as an added consideration we have chosen to forego any increase to our online training platforms. The adjustment to our Paper & Pencil and SASSI Online options resulted in a nominal average increase of 5%.

At The SASSI Institute, our mission is to support you in your vital work of screening, assessing and treating addiction. This minimal price increase is a step toward ensuring that we can continue to innovate, improve, and deliver the highest quality tools and services, as we continue to collaborate with you. We stand behind you in our mutual resolve that Early Intervention Saves Lives. We appreciate your understanding and continued trust in our products. Together, we can make a difference in the lives of those affected by addiction.

Change, while sometimes challenging, is often necessary for growth and improvement. The SASSI Institute remains steadfast in our dedication to providing exceptional tools and services. Thank you for your continued support and partnership.

Sincerely,

The SASSI Institute Team

2025 Product Sheet

Across the Pond and Beyond

Did you know that SASSI screening tools are available for use and are obtainable through our international distributors? If you are in, or have friends/colleagues in the UK, Australia, or Greece, please take note of our licensed distributors there for affordable access to SASSI screening tools.

In the UK, the paper & pencil version of the adult SASSI-4 and adolescent SASSI-A3 is available through SASSI Direct Ltd. For ordering information please email sassi@sassidirect.co.uk.

In Australia, the paper & pencil version of the adult SASSI-4 and adolescent SASSI-A3 is available through The Help Now Group. Since purchasing the web-based version of the SASSI through SASSI Online can be challenging for our Australian colleagues due to issues with credit card processing, access and administrations of the web-based version can also be purchased through The Help Now Group. For ordering information please email rodney@thehelpnow.org.

In Greece, a reliable and validated version of the translated adult SASSI-3 in Greek is available through Panagiota Kontoleon. For ordering information please email panagiota@kontoleon.com.gr.

We are pleased that these distributors are working with us to promote screening for those individuals suffering from substance use-related issues and disorders.

SASSI FAQs: Volume 1 | Customer IDs

We are excited to bring you a new series covering common questions on various topics specific to our processes and policies. In this edition of SASSI FAQs we take a quick look at Customer Identifiers or commonly referred to at SASSI as the Customer ID.

All accounts at The SASSI Institute are assigned a Customer ID. That account identifier consists of six characters, with the first two being letters representing the State (US) Province (CA) and ZZ for all other countries. The other four characters can be letters or numbers, but are consistent with the Organization’s name, or the last name of the clinician if the account represents a private practice. Our online shopping cart requires the Customer ID to check-out for paper products. If you do not know your Customer ID, or are a new customer, you can fill out the qualification form at www.sassi.com/qualify to receive a temporary ID so your order can be processed. For SASSI Online customers the Customer ID is found on the My Account tab, and most frequently used during technical support situations, or when an order is placed for the online account over the phone. When purchasing digital products, that form is part of the registration process at www.sassionline.com.

If you ever have any questions about your account, please reach out to our Customer Service Team! They are happy to help you navigate the qualification form and/or registration process. They can be reached at 800.726.0526 option 1 or via email at sassi@sassi.com.

Last Clinical Q&A Until Summer | Register Now!

We wanted to welcome you to join us for a free one-hour online SASSI Q&A session hosted by our Clinical Director, Kristin Kimmell, LCSW, LCAC. This will be our last free Q&A session until Summer.

The Q&A is scheduled from Noon-1pm ET on: April 16th. You can save your spot by clicking here. We welcome you to share profiles to discuss with the group by sending them (de-identified) via email any time prior to the session to scarlett@sassi.com. These profiles will help others learn about the SASSI and offer insight into the various profile configurations.

Note: Q&A sessions do not provide CEUs and are not a substitute for SASSI Training.

In-Person SASSI Trainings

Happy Spring! Our certified SASSI trainers have been busy doing live in-person training this year and would like to hear from you about the need in your local area for this service. Please visit the training page on our website to view a list of currently scheduled workshops at www.sassi.com/sassi-training. If nothing is scheduled in your area, please reach out directly to the trainer so they know there is interest in their area, and they can plan accordingly. They are also happy to schedule private in-person training for your agency/organization.

Reminder: Our clinical team is available M-F to answer questions about the administration, scoring, and interpretation of our instruments at 800.726.0526 option 2. This is a free service, and we encourage you to call often.

SASSI Online Tips and Tricks: Volume 7 | Distribution Groups

SASSI Online is our web-based platform that supports the digital administration of the Adult SASSI-4, Adolescent SASSI-A3, and Spanish SASSI. It provides a report with interpretive paragraphs outlining the decision rules and results from client responses.

In this edition of SASSI Online Tips and Tricks we highlight the Distribution Group feature available on the Purchasing & Distribution Tab of the Purchaser’s Account Dashboard. Distribution Groups can only be created and managed by the user that holds the Purchaser role on the account for the organization. Visit the My Account tab to find out who the Purchaser is for your organization’s account.

Distribution Groups are for organizations that have more than one counselor registered to administer questionnaires. They allow for the Purchaser to distribute a purchased quantity of questionnaires among registered counselors or groups within an organization. A distribution group can be named for an actual group (e.g., intake evaluations) or individual counselors (e.g., Carlisle) within an organization.

To create a new Distribution Group, Click the “Purchasing & Distribution” tab and then click the “Manage Distribution Groups” button. Then click on the “Create New Distribution Group” button and enter the name for your new distribution group, then click submit. Once a Distribution Group is created you will need to add questionnaires and counselors to the group. Click the respective buttons on the newly created group to complete this task. Continued management is required as counselors are added to the account and new questionnaires are purchased.

If your organization does not have a need to limit access to purchased questionnaires because all registered counselors will be sharing available questionnaires, then there is no need to create a Distribution Group. All SASSI Online accounts have a Default Distribution Group that all registered counselors and purchased questionnaires are automatically added to.

If you are not currently using SASSI Online and would like to experience the features of the digital platform, create an account at www.sassionline.com. If you already have an account, let us know if you have any suggestions for our next edition of SASSI Online Tips and Tricks. As a bonus for reading this blog post to the end, reach out to us at blog@sassi.com, with the code phrase: Distribution Group, to request two free SASSI Online administrations!

Adolescent SASSI-A3 Review: High Probability Result with a VAL of 6

This adolescent male profile presents some initial complications for the reviewer in regards to the clinical interpretation as seen on the graph. The face valid scales fall either within the norm or below the norm. One of the subtle scales is above the 85th percentile so is clinically significant, and another is below the norm. An examination of the scales produces useful information to guide the discussion of the results with the client and directing appropriate treatment considerations.

This 17-year-old male completed the FVA/FVOD side of the questionnaire for his whole lifetime.

The VAL is 6.

Rx Scale is 0.

High Probability of a Substance Use Disorder is based on Rule 6.

Rule 6: a. FVOD 7 or more. (8)

            b. FRISK or ATT or SYM is 3 or more. (SYM – 3).

            c. OAT 5 or more (7).

Clinical Discussion

The FVOD of 8 is above average and should be noted. Examining those particular questions, he endorsed will provide the groundwork for how and under what circumstance he is using drugs. With the FRISK (0) and ATT (1) scores so low, his use is not necessarily tied to his peers, nor does he have a belief or value system that supports the idea that everyone uses substances. Looking at his one ATT score will help to evaluate any beliefs he may hold around substances.

The SYM (3) score is above average and again, because it is a face valid scale, content analysis will provide information regarding the consequences that he does acknowledge.

The OAT (7) scale is significant because it is elevated above the 85th percentile. This is the subtle scale that you want elevated as it indicates someone who can acknowledge limitations and shortcomings. He can probably identify with other substance users and those behaviors represented in that population such as impatience, resentment, self-pity, or impulsiveness. This, of course, does not mean he wants to or believes that he can change. But this information can be used as a positive to recognize the insights he may have around his use.

The low SAT (1) score (below the 15th percentile) gives some clues on how best to approach this client. This score indicates he is very hypersensitive to what others think about him. He may come across as having a chip on his shoulder so tread lightly!

The DEF (8) score, though above average, is still within the norm so does not indicate significant defensiveness on the client’s part.

The SAM (3) and COR (3) have no clinical significance.

Does the VAL score of 6 impact the results? Given the outcome was High Probability based on Rule 6, the impact is nil. The VAL is significant only if the outcome was Low Probability. However, with that score, the evaluator may hypothesize that perhaps the client was trying to skew the results but failed.

Questions remain regarding the current use of substances by the client. Is he minimizing his use or is he presenting an accurate picture? He was not defensive so perhaps his overriding concern was how he was viewed by the evaluator.

Treatment Considerations

Recommendations for the level of treatment need to be considered if he does have a diagnosable disorder based on the DSM-5. Actual current use also needs to be established. The elevated OAT score does indicate he will not feel out of place in a group setting. Prior history of substance use issues also need to be considered. It would appear, however, that outpatient treatment would be a consideration with the level of intervention to be determined by the overall assessment.

We recommend administrators of the SASSI have access to The Adolescent SASSI-A3 User Guide and Manual. It contains information on scoring, interpreting profiles and includes examples of profiles. It defines all the scales, what they represent, clinical considerations and giving feedback. The Manual also contains the research and validation information. Please call our Customer Service number for more information on how to order – 800-726-0526.

PDF Version Available for Download